Zobrazeno 1 - 10
of 30
pro vyhledávání: '"HbA1c, glycated haemoglobin"'
Publikováno v:
Indian Heart Journal, Vol 72, Iss 4, Pp 312-315 (2020)
Indian Heart Journal
Indian Heart Journal
Sulphonylureas (SU) form an important role in management of people with type 2 diabetes. This safety history of SU was tainted for various reasons, the predominant one being lack of demonstration of cardiovascular safety. Since its introduction, SU's
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5606b68bef5859699202276c33df40ca
http://www.sciencedirect.com/science/article/pii/S001948322030167X
http://www.sciencedirect.com/science/article/pii/S001948322030167X
Autor:
Stuart McPherson, Marc Herscovitz, Jonathan Vernazza, Quentin M. Anstee, Dina Mansour, Andrea Broad, Paul Cassidy, Allison Grapes
Publikováno v:
JHEP Reports, Vol 3, Iss 4, Pp 100293-(2021)
JHEP Reports
JHEP Reports
Background & Aims Individuals with type 2 diabetes (T2DM) are at high risk of developing non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis/cirrhosis. Screening patients with T2DM and normal liver enzymes for NAFLD in primary care remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1336cef2de43968549cc7d868da73a54
http://www.sciencedirect.com/science/article/pii/S2589555921000690
http://www.sciencedirect.com/science/article/pii/S2589555921000690
Autor:
Jonatan I. Bagger, Tina Vilsbøll, Filip K. Knop, Benjamin Lelouvier, Malte P. Suppli, Charlotte Strandberg, Amandine Broha, Mia Demant, Merete J Kønig, Asger Lund
Publikováno v:
JHEP Reports, Vol 3, Iss 4, Pp 100299-(2021)
JHEP Reports
Suppli, M P, Bagger, J I, Lelouvier, B, Broha, A, Demant, M, Kønig, M J, Strandberg, C, Lund, A, Vilsbøll, T & Knop, F K 2021, ' Hepatic microbiome in healthy lean and obese humans ', JHEP Reports, vol. 3, no. 4, 100299 . https://doi.org/10.1016/j.jhepr.2021.100299
JHEP Reports
Suppli, M P, Bagger, J I, Lelouvier, B, Broha, A, Demant, M, Kønig, M J, Strandberg, C, Lund, A, Vilsbøll, T & Knop, F K 2021, ' Hepatic microbiome in healthy lean and obese humans ', JHEP Reports, vol. 3, no. 4, 100299 . https://doi.org/10.1016/j.jhepr.2021.100299
Background & Aims Dysbiosis of the gut microbiota in response to an energy-rich Western diet and the potential leak of bacteria and/or bacterial products from the intestine to the liver is perceived as a potential risk factor for the development of n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23eee827bacdf1b0e217e24af3bd81a5
http://www.sciencedirect.com/science/article/pii/S2589555921000756
http://www.sciencedirect.com/science/article/pii/S2589555921000756
Autor:
Petia Shipkova, Giridhar S. Tirucherai, Arun J. Sanyal, Diane E. Shevell, Benjamin E. Decato, Colleen A. McNaney, Yi Luo, Edgar D. Charles, Abraham Apfel
Publikováno v:
JHEP Reports
Background & Aims Increased serum bile acids (BAs) have been observed in patients with non-alcoholic steatohepatitis (NASH). Pegbelfermin (PGBF), a polyethylene glycol-modified (PEGylated) analogue of human fibroblast growth factor 21 (FGF21), signif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c523b47362c4cc87193b195c73edfb6d
https://pubmed.ncbi.nlm.nih.gov/34977519
https://pubmed.ncbi.nlm.nih.gov/34977519
Publikováno v:
Journal of Nutritional Science
There are two proven dietary approaches to shift type 2 diabetes (T2D) into remission: low energy diets (LED) and low carbohydrate diets (LCD). These approaches differ in their rationale and application yet both involve carbohydrate restriction, eith
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f61c812d42cf3ec23755a07ec4aa1c9b
https://doi.org/10.1101/2021.05.07.21256843
https://doi.org/10.1101/2021.05.07.21256843
Autor:
Grzych, Guillaume, Chavez-Talavera, Oscar, Descat, Amandine, Thuillier, Dorothee, Verrijken, An, Kouach, Mostafa, Legry, Vanessa, Verkindt, Helene, Raverdy, Violeta, Legendre, Benjamin, Caiazzo, Robert, Van Gaal, Luc, Goossens, Jean-Francois, Paumelle, Rejane, Francque, Sven, Pattou, Francois, Haas, Joel T., Tailleux, Anne, Staels, Bart
Publikováno v:
JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, 2021, 3 (2), pp.100222. ⟨10.1016/j.jhepr.2020.100222⟩
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100222. ⟨10.1016/j.jhepr.2020.100222⟩
JHEP Reports
JHEP Reports, Vol 3, Iss 2, Pp 100222-(2021)
JHEP Reports Innovation in Hepatology, 2021, 3 (2), pp.100222. ⟨10.1016/j.jhepr.2020.100222⟩
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100222. ⟨10.1016/j.jhepr.2020.100222⟩
JHEP Reports
JHEP Reports, Vol 3, Iss 2, Pp 100222-(2021)
Background & Aims Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the association of NASH with type 2 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::74e69ecb4a62b415846d1ee012802a9c
https://www.hal.inserm.fr/inserm-03173334/document
https://www.hal.inserm.fr/inserm-03173334/document
Autor:
Amelie Isabelle Sylvie Sobczak, Alan J. Stewart, Terry K. Smith, Ramzi A. Ajjan, Samantha J. Pitt
Publikováno v:
Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids
Type-1 diabetes mellitus (T1DM) is associated with metabolic changes leading to alterations in glucose and lipid handling. While T1DM-associated effects on many major plasma lipids have been characterised, such effects on plasma free fatty acids (FFA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::618c06055f97e3272a7544ca364e1fcd
http://europepmc.org/articles/PMC7695620
http://europepmc.org/articles/PMC7695620
Autor:
Oveis Jamialahmadi, Antonio Picardi, Luca Valenti, Roberta Pujia, Federica Tavaglione, Umberto Vespasiani-Gentilucci, Stefano Romeo, Antonio De Vincentis, Rocco Spagnuolo, Susanna Morano
Publikováno v:
JHEP Reports, Vol 3, Iss 3, Pp 100262-(2021)
JHEP Reports
JHEP Reports
Background & Aims Type 2 diabetes is a major driver of fatty liver disease and its long-term complications. The aim of this study was to investigate the individual contribution of inborn and acquired risk factors for severe liver disease in individua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3548cf2562154577ca36519f424df8d4
https://pubmed.ncbi.nlm.nih.gov/33997749
https://pubmed.ncbi.nlm.nih.gov/33997749
Publikováno v:
Practical Laboratory Medicine, Vol 8, Iss, Pp 26-29 (2017)
Practical Laboratory Medicine
Practical Laboratory Medicine
Aims: As the use of Point of Care Testing (POCT) devices for measurement of glycated haemoglobin (HbA1c) increases, it is imperative to determine how their performance compares to laboratory methods. This study compared the performance of the automat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fcda08ebe4afd4a0da878b49e2a37cb
http://www.sciencedirect.com/science/article/pii/S2352551717300021
http://www.sciencedirect.com/science/article/pii/S2352551717300021
Publikováno v:
JHEP Reports, Vol 3, Iss 1, Pp 100197-(2021)
JHEP Reports
JHEP Reports
Background & Aims Sarcopenia and frailty are recognised as important factors in later stages of liver disease. However, their role in non-alcoholic fatty liver disease (NAFLD) is not yet fully understood. In this study we investigate the associations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a64b7d5e87e73ceb0598021536bc3699
https://doi.org/10.1016/j.jhepr.2020.100197
https://doi.org/10.1016/j.jhepr.2020.100197